Integrating B cell homeostasis and selection with BLyS

Archivum Immunologiae et Therapiae Experimentalis

Volumn 51, Issue 4, 2003, Pages 209-218

  Smith, Susan Harless ^a   Cancro, Michael P ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

B lymphocytes; BLyS; Development; Homeostasis

Indexed keywords

B LYMPHOCYTE ANTIGEN; B LYMPHOCYTE STIMULATOR; LYMPHOCYTE ANTIGEN RECEPTOR; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CELL SELECTION; HOMEOSTASIS; HUMAN; LIFESPAN; LONGEVITY; MEMORY CELL; PRE B LYMPHOCYTE; REVIEW;

ANIMALS; B-CELL ACTIVATING FACTOR; B-CELL ACTIVATION FACTOR RECEPTOR; B-LYMPHOCYTES; CELL DIFFERENTIATION; CELL SURVIVAL; HOMEOSTASIS; IMMUNOLOGIC MEMORY; LYMPHOCYTE ACTIVATION; MEMBRANE PROTEINS; RECEPTORS, TUMOR NECROSIS FACTOR; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0042426167     PISSN: 0004069X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (114)

1. ADAMS J. M., HUANG D. C., PUTHALAKATH H., BOUILLET P., VAIRO G., MORIISHI K., HAUSMANN G., O'REILLY L., NEWTON K., OGILVY S., BATH M. L., PRINT C. G., HARRIS A. W., STRASSER A. and CORY S. (1999): Control of apoptosis in hematopoietic cells by the Bcl-2 family of proteins. Cold Spring Harb. Symp. Quant. Biol., 64, 351-358.
2. AGENES F. and FREITAS A. A. (1999): Transfer of small resting B cells into immunodeficient hosts results in the selection of a self-renewing activated B cell population. J. Exp. Med., 189, 319-330.
3. AGENES F., ROSADO M. M. and FREITAS A. A. (1997): Independent homeostatic regulation of B cell compartments. Eur. J. Immunol., 27, 1801-1807.
4. AGENES F., ROSADO M. M. and FREITAS A. A. (2000): Considerations on B cell homeostasis. Curr. Top. Microbiol. Immunol., 252, 68-75.
5. AGENES F., ROSADO M. M. and FREITAS A. A. (2000): Peripheral B cell survival. Cell Mol. Life Sci., 57, 1220-1228.
6. hi and exhibit unique signaling characteristics. J. Immunol., 149, 2533-2540.
7. hi splenic B cells are an immature developmental intermediate in the production of long-lived marrow-derived B cells. J. Immunol., 151, 4431-4444.
8. ALLMAN D., LINDSLEY R. C., DEMUTH W., RUDD K., SHINTON S. A. and HARDY R. R. (2001): Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation. J. Immunol., 167, 6834-6840.
9. AMBROSE C. M. (2002): BAFF-R. J. Biol. Regul. Homeost. Agents, 16, 211-213.
10. BANNISH G., FUENTES-PANANA E. M., CAMBIER J. C., PEAR W. S. and MONROE J. G. (2001): Ligand-independent signaling functions for the B lymphocyte antigen receptor and their role in positive selection during B lymphopoiesis. J. Exp. Med., 194, 1583-1596.
11. BATTEN M., GROOM J., CACHERO T. G., QIAN F., SCHNEIDER P., TSCHOPP J., BROWNING J. L. and MACKAY F. (2000): BAFF mediates survival of peripheral immature B lymphocytes. J. Exp. Med., 192, 1453-1466.
12. CAMBIER J., KETTMAN J., VITETTA E. and UHR J. (1976): Differential susceptibility of neonatal and adult murine spleen cells to in vitro induction of B-cell tolerance. J. Exp. Med., 144, 293-297.
13. CANCRO M. P., ALLMAN D. M., HAYES C. E., LENTZ V. M., FIELDS R. G., SAH A. P. and TOMAYKO M. (1998): B cell maturation and selection at the marrow-periphery interface. Immunol. Res., 17, 3-11.
14. CARSETTI R., KOHLER G. and LAMERS M. C. (1995): Transitional B cells are the target of negative selection in the B cell compartment. J. Exp. Med., 181, 2129-2140.
15. CLISE-DWYER K., AMANNA I. J., DUZESKI J. L., NASHOLD F. E. and HAYES C. E. (2001): Genetic studies of B-lymphocyte deficiency and mastocytosis in strain A/WySnJ mice. Immunogenetics, 53, 729-735.
16. CORY S. (1995): Regulation of lymphocyte survival by the bcl-2 gene family. Ann. Rev. Immunol., 13, 513-543.
17. CYSTER J. G., HARTLEY S. B. and GOODNOW C. C. (1994): Competition for follicular niches excludes self-reactive cells from the recirculating B-cell repertoire. Nature, 371, 389-395.
18. DE BOER R. J., FREITAS A. A. and PERELSON A. S. (2001): Resource competition determines selection of B cell repertoires. J. Theor. Biol., 212, 333-343.
19. DEFRANCE T., CASAMAYOR-PALLEJA M. and KRAMMER P. H. (2002): The life and death of a B cell. Adv. Cancer Res., 86, 195-225.
20. DO R. K. and CHEN-KIANG S. (2002): Mechanism of BLyS action in B cell immunity. Cytokine Growth Factor Rev., 13, 19-25.
21. DO R. K., HATADA E., LEE H., TOURIGNY M. R., HILBERT D. and CHEN-KIANG S. (2000): Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response. J. Exp. Med., 192, 953-964.
22. FREITAS A. A., ROSADO M. M., VIALE A. C. and GRANDIEN A. (1995): The role of cellular competition in B cell survival and selection of B cell repertoires. Eur. J. Immunol., 25, 1729-1738.
23. FULCHER D. A. and BASTEN A. (1994): Reduced life span of anergic self-reactive B cells in a double-transgenic model. J. Exp. Med., 179, 125-134.
24. FULCHER D. A. and BASTE A. (1994): Whither the anergic B-cell? Autoimmunity, 19, 135-140.
25. FULOP G., GORDON J. and OSMOND D. G. (1983): Regulation of lymphocyte production in the bone marrow. I. Turnover of small lymphocytes in mice depleted of B lymphocytes by treatment with anti-IgM antibodies. J. Immunol., 130, 644-648.
26. GAY D., SAUNDERS T., CAMPER S. and WEIGERT M. (1993): Receptor editing: an approach by autoreactive B cells to escape tolerance. J. Exp. Med., 177, 999-1008.
27. GIBSON L. F., PIKTEL D., NARAYANAN R., NUNEZ G. and LANDRETH K. S. (1996): Stromal cells regulate bcl-2 and bax expression in pro-B cells. Exp. Hematol., 24, 628-637.
28. GOODNOW C. C., CROSBIE J., JORGENSEN H., BRINK R. A. and BASTEN A. (1989): Induction of self-tolerance in mature peripheral B lymphocytes. Nature, 342, 385-391.
29. GOODNOW C. C., CYSTER J. G., HARTLEY S. B., BELL S. E., COOKE M. P., HEALY J. I., AKKARAJU S., RATHMELL J. C., POGUE S. L. and SHOKAT K. P. (1995): Self-tolerance checkpoints in B lymphocyte development. Adv. Immunol., 59, 279-368.
30. GRILLOT D. A., MERINO R., PENA J. C., FANSLOW W. C., FINKELMAN F. D., THOMSON C. B. and NUNEZ G. (1996): Bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J. Exp. Med., 183, 381-391.
31. GROSS J. A., DILLON S. R., MUDRI S., JOHNSTON J., LITTAU A., ROQUE R., RIXON M., SCHOU O., FOLEY K. P., HAUGEN H., MCMILLEN S., WAGGIE K., SCHRECKHISE R. W., SHOEMAKER K., VU T., MOORE M., GROSSMAN A. and CLEGG C. H. (2001): TACI-Ig neutralizes molecules critical for B cell development and autoimmune disease. Impaired B cell maturation in mice lacking BLyS. Immunity, 15, 289-302.
32. GROSS J. A., JOHNSTON J., MUDRI S., ENSELMAN R., DILLON S. R., MADDEN K., XU W., PARRISH-NOVAK J., FOSTER D., LOFTON-DAY C., MOORE M., LITTAU A., GROSSMAN A., HAUGEN H., FOLEY K., BLUMBERG H., HARRISON K., KINDSVOGEL W. and CLEGG C. H. (2000): TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature, 404, 995-999.
33. GU H., TARLINTON D., MULLER W., RAJEWSKY K. and FORSTER I. (1991): Most peripheral B cells in mice are ligand selected. J. Exp. Med., 173, 1357-1371.
34. HAHNE M., KATAOKA T., SCHROTER M., HOFMANN K., IRMLER M., BODMER J. L., SCHNEIDER P., BORNAND T., HOLLER N., FRENCH L. E., SORDAT B., RIMOLDI D. and TSCHOPP J. (1998): APRIL, a new ligand of the tumor necrosis factor family, stimulates tumor cell growth. J. Exp. Med., 188, 1185-1190.
35. HARLESS S. M., LENTZ V. M., SAH A. P., HSU B. L., CLISE-DWYER K., HILBERT D. M., HAYES C. E. and CANCRO M. P. (2001): Competition for BLyS-mediated signaling through Bcmd/BR3 regulates peripheral B lymphocyte numbers. Curr. Biol., 11, 1986-1989.
36. HARTLEY S. B., COOKE M. P., FULCHER D. A., HARRIS A., CORY S., BASTEN A. and GOODNOW C. C. (1993): Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell, 72, 325-335.
37. Hsu B. L., HARLESS S. M., LINDSLEY R. C., HILBERT D. M. and CANCRO M. P. (2002): Cutting edge: BLyS enables survival of transitional and mature B cells through distinct mediators. J. Immunol., 168, 5993-5996.
38. KALLED S. L. (2002): BAFF: a novel therapeutic target for autoimmunity. Curr. Opin. Invest. Drugs, 3, 1005-1010.
39. KHARE S. D. and HSU H. (2001): The role of TALL-1 and APRIL in immune regulation. Trends Immunol., 22, 61-63.
40. KHARE S. D., SAROSI I., XIA X. Z., MCCABE S., MINER K., SOLOVYEV I., HAWKINS N., KELLEY M., CHANG D., VAN G., ROSS L., DELANEY J., WANG L., LACEY D., BOYLE W. J. and Hsu H. (2000): Severe B cell hyperplasia and autoimmune disease in TALL-1 transgenic mice. Proc. Natl. Acad. Sci. USA, 97, 3370-3375.
41. KORSMEYER S. J. (1995): Regulators of cell death. Trends Genet., 11, 101-105.
42. LAABI Y., GRAS M. P., BROUET J. C., BERGER R., LARSEN C. J. and TSAPIS A. (1994): The BCMA gene, preferentially expressed during B lymphoid maturation, is bidirectionally transcribed. Nucleic Acids Res., 22, 1147-1154.
43. LAABI Y. and STRASSER A. (2000): Immunology. Lymphocyte survival - ignorance is BLyS. Science, 289, 883-884.
44. LAM K. P., KUHN R. and RAJEWSKY K. (1997): In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell, 90, 1073-1083.
45. LENTZ V. M. (1997): Bcmd governs recruitment of newly formed B-2 cells into the stable peripheral B cell pool. Doctoral thesis, University of Pennsylvania, USA.
46. LENTZ V. M., CANCRO M. P., NASHOLD F. E. and HAYES C. E. (1996): Bcmd governs recruitment of new B cells into the stable peripheral B cell pool in the A/WySnJ mouse. J. Immunol., 157, 598-606.
47. LENTZ V. M., HAYES C. E. and CANCRO M. P. (1998): Bcmd decreases the life span of B-2 but not B-1 cells in A/WySnJ mice. J. Immunol., 160, 3743-3747.
48. LEVINE M. H., HABERMAN A. M., SANT'ANGELO D. B., HANNUM L. G., CANCRO M. P., JANEWAY C. A. JR. and SHLOMCHIK M. J. (2000): A B-cell receptor-specific selection step governs immature to mature B cell differentiation. Proc. Natl. Acad. Sci. USA, 97, 2743-2748.
49. LI Y. S., HAYAKAWA K. and HARDY R. R. (1993): The regulated expression of B lineage associated genes during B cell differentiation in bone marrow and fetal liver. J. Exp. Med., 178, 951-960.
50. LITINSKIY M. B., NARDELLI B., HILBERT D. M., HE B., SCHAFFER A., CASALI P. and CERUTTI A. (2002): DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat. Immunol., 3, 822-829.
51. LIU Y. J., MASON D. Y., JOHNSON G. D., ABBOT S., GREGORY C. D., HARDIE D. L., GORDON J. and MACLENNAN I. C. (1991): Germinal center cells express Bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur. J. Immunol., 21, 1905-1910.
52. LODER F., MUTSCHLER B., RAY R. J., PAIGE C. J., SIDERAS P., TORRES R., LAMERS M. C. and CARSETTI R. (1999): B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med., 190, 75-89.
53. MACKAY F. and BROWNING J. L. (2002): BAFF: a fundamental survival factor for B cells. Nat. Rev. Immunol., 2, 465-475.
54. MACKAY F. and MACKAY C. R. (2002): The role of BAFF in B-cell maturation, T-cell activation and autoimmunity. Trends Immunol., 23, 113-115.
55. MACKAY F., WOODCOCK S. A., LAWTON P., AMBROSE C., BAETSCHER M., SCHNEIDER P., TSCHOPP J. and BROWNING J. L. (1999): Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J. Exp. Med., 190, 1697-1710.
56. MACPHERSON A. J. and LAMARRE A. (2002): BLySsful interactions between DCs and B cells. Nat Immunol., 3, 798-800.
57. MADRY C., LAABI Y., CALLEBAUT I., ROUSSEL J., HATZOGLOU A., LE CONIAT M., MORNON J. P., BERGER R. and TSAPIS A. (1998): The characterization of murine BCMA gene defines it as a new member of the tumor necrosis factor receptor superfamily. Int Immunol., 10, 1693-1702.
58. MAK T. W. and YEH W. C. (2002): Signaling for survival and apoptosis in the immune system. Arthritis Res., 4 (suppl. 3), S243-252.
59. MANDIK-NAYAK L., BUI A., NOORCHASHM H., EATON A. and ERIKSON J. (1997): Regulation of anti-double-stranded DNA B cells in nonautoimmune mice: localization to the T-B interface of the splenic follicle. J. Exp. Med., 186, 1257-1267.
60. MCDONNELL T. J., DEANE N., PLATR F. M., NUNEZ G., JAEGER U., MCKEARN J. P. and KORSMEYER S. J. (1989): Bcl-2-immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation. Cell, 57, 79-88.
61. MCLEAN A. R., ROSADO M. M., AGENES F., VASCONCELLOS R. and FREITAS A. A. (1997): Resource competition as a mechanism for B cell homeostasis. Proc. Natl. Acad. Sci. USA, 94, 5792-5797.
62. MERINO R., DING L., VEIS D., KORSMEYER S. and NUNEZ G. (1994): Developmental regulation of the Bcl-2 protein and susceptibility to cell death in B lymphocytes. EMBO J., 13, 683-691.
63. METCALF E. and KLINMAN N. (1976): In vitro tolerance induction don of neonatal murine B cells. J. Exp. Med., 143, 1327-1340.
64. METCALF E. and KLINMAN N. (1977): In vitro tolerance induction of bone marrow cells: a marker for B cell maturation. J. Immunol., 118, 2111-2116.
65. MILLER D. J., HANSON K. D., CARMAN J. A. and HAYES C. E. (1992): A single autosomal gene defect severely limits IgG but not IgM responses in B lymphocyte-deficient A/WySnJ mice. Eur. J. Immunol., 22, 373-379.
66. MILLER D. J. and HAYES C. E. (1991): Phenotypic and genetic characterization of a unique B lymphocyte deficiency in strain A/WySnJ mice. Eur. J. Immunol., 21, 1123.
67. MOORE P. A., BELVEDERE O., ORR A., PIERI K., LAFLEUR D. W., FENG P., SOPPET D., CHARTERS M., GENTZ R., PARMELEE D., LI Y., GALPERINA O., GIRI J., ROSCHKE V., NARDELLI B., CARRELL J., SOSNOVTSEVA S., GREENFIELD W., RUBEN S. M., OLSEN H. S., FIKES J. and HILBERT D. M. (1999): BLyS: mem ber of the tumor necrosis factor family and B lymphocyte stimulator. Science, 285, 260-263.
68. MUKHOPADHYAY A., NI J., ZHAI Y., YU G. L. and AGGARWAL B. B. (1999): Identification and characterization of a novel cytokine, THANK, a TNF homologue that activates apoptosis, nuclear factor-κB, and c-Jun NH2-terminal kinase. J. Biol. Chem., 274, 15978-15981.
69. NEMAZEE D. A. and BURKI K. (1989): Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature, 337, 562-566.
70. NEMAZEE D., RUSSELL D., ARNOLD B., HAEMMERLING G., ALLISON J., MILLER J. F., MORAHAN G. and BUERKI K. (1991): Clonal deletion of autospecific B lymphocytes. Immunol. Rev., 122, 117-132.
71. NEMAZEE D. and WEIGERT M. (2000): Revising B cell receptors. J. Exp. Med., 191, 1813-1817.
72. NOSSAL G. J. (1997): B lymphocyte physiology: the beginning and the end. Ciba Found Symp., 204, 220-230; discussion 230-231.
73. NOSSAL G. J. (1983): Cellular mechanisms of immunological tolerance. Ann. Rev. Immunol., 1, 33-62.
74. NOSSAL G. and PIKE B. (1975): Evidence for the clonal abortion theory of B-lymphocyte tolerance. J. Exp. Med., 141, 904-917.
75. NUNEZ G., MERINO R., GRILLOT D. and GONZALEZ-GARCIA M. (1994): Bcl-2 and Bcl-x: regulatory switches for lymphoid death and survival. Immunol. Today, 15, 582-588.
76. O'REILLY L. A., HARRIS A. W., TARLINTON D. M., CORCORAN L. M. and STRASSER A. (1997): Expression of a bcl-2 transgene reduces proliferation and slows turnover of developing B lymphocytes in vivo. J. Immunol., 159, 2301-2311.
77. OSMOND D. G. (1986): Population dynamics of bone marrow B lymphocytes. Immunol. Rev., 93, 103-124.
78. OSMOND D. G. (1993): The turnover of B cell populations. Immunol. Today, 14, 34-37.
79. OSMOND D. G. and GORDON J. (1979): Characterization of small lymphocytes in the bone marrow of mice after prolonged treatment with anti-IgM antibodies. Cell. Immunol., 42, 188-193.
80. OSMOND D. G. and PARK Y. H. (1987): B lymphocyte progenitors in mouse bone marrow. Int. Rev. Immunol., 2, 241-260.
81. POUND J. (2001): A key role for BAFF in maintaining peripheral B cells. Trends Immunol., 22, 659.
82. PRAK E. L., TROUNSTINE M., HUSZAR D. and WEIGERT M. (1994): Light chain editing in κ-deficient animals: a potential mechanism of B cell tolerance. J. Exp. Med., 180, 1805-1815.
83. RENNERT P., SCHNEIDER P., CACHERO T. G., THOMPSON J., TRABACH L., HERTIG S., HOLLER N., QIAN F., MULLEN C., STRAUCH K., BROWNING J. L., AMBROSE C. and TSCHOPP J. (2000): A soluble form of B cell maturation antigen, a receptor for the tumor necrosis factor family member APRIL, inhibits tumor cell growth. J. Exp. Med., 192, 1677-1684.
84. ROLINK A. G., ANDERSSON J. and MELCHERS F. (1998): Characterization of immature B cells by a novel monoclonal antibody, by turnover and by mitogen reactivity. Eur. J. Immunol., 28, 3738-3748.
85. ROLINK A. G. and MELCHERS F. (2002): BAFFled B cells survive and thrive: roles of BAFF in B-cell development. Curr. Opin. Immunol., 14, 266-275.
86. ROLINK A. G., TSCHOPP J., SCHNEIDER P. and MELCHERS F. (2002): BAFF is a survival and maturation factor for mouse B cells. Eur. J. Immunol., 32, 2004-2010.
87. ROSADO M. M. and FREITAS A. A. (1998): The role of the B cell receptor V region in peripheral B cell survival. Eur. J. Immunol., 28, 2685-2693.
88. RUSSELL D., DEMBIC Z., MORAHAN G., MILLER J., BURKI K. and NEMAZEE D. (1991): Peripheral deletion of self-reactive B cells. Nature, 354, 308-311.
89. SCHIEMANN B., GOMMERMAN J. L., VORA K., CACHERO T. G., SHULGA-MORSKAYA S., DOBLES M., FREW E. and SCOTT M. L. (2001): An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway. Science, 293, 2111-2114.
90. SCHNEIDER P., MACKAY F., STEINER V., HOFMANN K., BODMER J. L., HOLLER N., AMBROSE C., LAWTON P., BIXLER S., ACHA-ORBEA H., VALMORI D., ROMERO P., WERNER-FAVRE C., ZUBLER R. H., BROWNING J. L. and TSCHOPP J. (1999): BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J. Exp. Med., 189, 1747-1756.
91. SHU H. B., HU W. H. and JOHNSON H. (1999): TALL-1 is a novel member of the TNF family that is down-regulated by mitogens. J. Leukoc. Biol., 65, 680-683.
92. SPRENT J. (1977): Migration and lifespan of lymphocytes. In ROELANTS F. and LA G. E. (eds.): B and T cells in immune recognition. John Wiley and Sons, New York, 59-82.
93. SPRENT J. and BASTEN A. (1973): Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell. Immunol., 7, 40.
94. SPRENT J. and TOUGH D. F. (1994): Lymphocyte life-span and memory. Science, 265, 1395-1400.
95. STEIN J. V., LOPEZ-FRAGA M., ELUSTONDO F. A., CARVALHO-PINTO C. E., RODRIGUEZ D., GOMEZ-CARO R., DE JONG J., MARTINEZ A. C., MEDEMA J. P. and HAHNE M. (2002): APRIL modulates B and T cell immunity. J. Clin. Invest., 109, 1587-1598.
96. STOHL W. (2002): B lymphocyte stimulator protein levels in systemic lupus erythematosus and other diseases. Curr. Rheumatol. Rep., 4, 345-350.
97. + T cells: lessons from HIV-infected patients. Clin. Immunol., 104, 115-122.
98. STRASSER A., HARRIS A. W., CORCORAN L. M. and CORY S. (1994): Bcl-2 expression promotes B- but not T-lymphoid development in scid mice. Nature, 368, 457-460.
99. STRASSER A., O'CONNOR L., HUANG D. C., O'REILLY L. A., STANLEY M. L., BATH M. L., ADAMS J. M., CORY S. and HARRIS A. W. (1996): Lessons from bcl-2 transgenic mice for immunology, cancer biology and cell death research. Behring Institute Mitteilungen, 97, 101-117.
100. STRASSER A., WHITTINGHAM S., VAUX D. L., BATH M. L., ADAMS J. M., CORY S. and HARRIS A. W. (1991): Enforced Bcl2 expression in B-lymphoid cells prolongs antibody responses and elicits autoimmune disease. Proc. Natl. Acad. Sci. USA, 88, 8661-8665.
101. THOMPSON J. S., BIXLER S. A., QIAN F., VORA K., SCOTT M. L., CACHERO T. G., HESSION C., SCHNEIDER P., SIZING I. D., MULLEN C., STRAUCH K., ZAFARI M., BENJAMIN C. D., TSCHOPP J., BROWNING J. L. and AMBROSE C. (2001): BAFF-R, a novel TNF receptor that specifically interacts with BAFF. Science, 293, 2108-2111.
102. TIEGS S. L., RUSSELL D. M. and NEMAZEE D. (1993): Receptor editing in self-reactive bone marrow B cells. J. Exp. Med., 177, 1009-1020.
103. TOMAYKO M. M. and CANCRO M. P. (1998): Long-lived B cells are distinguished by elevated expression of Al. J. Immunol., 160, 107-111.
104. TURNER M., GULBRANSON-JUDGE A., QUINN M. E., WALTERS A. E., MACLENNAN I. C. and TYBULEWICZ V. L. (1997): Syk tyrosine kinase is required for the positive selection of immature B cells into the recirculating B cell pool. J. Exp. Med., 186, 2013-2021.
105. TYLER R. W. and EVERETT N. B. (1972): Radioautographic study of cellular migration using parabiotic rats. Blood, 39, 249-266.
106. VAUX D. L. (2002): The buzz about BAFF. J. Clin. Invest., 109, 17-18.
107. VON BULOW G. U. and BRAM R. J. (1997): NF-AT activation induced by a CAML-interacting member of the tumor necrosis factor receptor superfamily. Science, 278, 138-141.
108. WALDSCHMIDT T. J. and NOELLE R. J. (2001): Immunology. Long live the mature B cell - a baffling mystery resolved. Science, 293, 2012-2013.
109. WALDSCHMIDT T. and VITETTA E. (1985): The use of haptenated-immunoglobulin molecules to induce tolerance in B cells from neonatal mice. J. Immunol., 134, 1436-1441.
110. Xu L. G., Wu M., Hu J., ZHAI Z. and SHU H. B. (2002): Identification of downstream genes up-regulated by the tumor necrosis factor family member TALL-1. J. Leukoc. Biol., 72, 410-416.
111. YAN M., BRADY J. R., CHAN B., LEE W. P., HSU B., HARLESS S., CANCRO M., GREWAL I. S. and DIXIT V. M. (2001): Identification of a novel receptor for B lymphocyte stimulator (BLyS) that is mutated in a mouse strain with severe B cell deficiency. Curr. Biol., 11, 1547-1552.
112. YAN M., WANG H., CHAN B., ROOSE-GIRMA M., ERICKSON S., BAKER T., TUMAS D., GREWAL I. S. and DIXIT V. M. (2001): Activation and accumulation of B cells in TACI-deficient mice. Nat. Immunol., 2, 638643.
113. YOSHIDA Y. and OSMOND D. G. (1971): Identity and proliferation of small lymphocyte precursors in cultures of lymphocyte-rich fractions of guinea pig bone marrow. Blood, 37, 73-86.
114. Yu G., BOONE T., DELANEY J., HAWKINS N., KELLEY M., RAMAKRISHNAN M., MCCABE S., QIU W. R., KORNUC M., XIA X. Z., Guo J., STOLINA M., BOYLE W. J., SAROSI I., HSU H., SENALDI G. and THEILL L. E. (2000): APRIL and TALL-1 and receptors BCMA and TACI: system for regulating humoral immunity. Nat. Immunol., 1, 252-256.